Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
admin Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read MoreSeagen Inc.
Merck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. MRK XE:MRK is in advanced talks to acquire Seagen Inc. SGEN and…
Read More
Get ready for more merger mania in pharma sector the rest of the year
Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is…
Read More